Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation

Area of Science:

• Hematology
• Immunology
• Transplantation Medicine

Background:

• Red cell-incompatible hematopoietic progenitor cell transplantation affects 30-50% of patients.
• Complications include hemolytic transfusion reactions and delayed red blood cell recovery, involving ABO, Kidd, and rhesus systems.
• Passenger lymphocytes in the graft can cause delayed hemolysis and pure red cell aplasia.

Purpose of the Study:

• To review the immunohematological consequences of red cell-incompatible transplantation.
• To assess the impact of red cell antigen disparities on transplant outcomes, including graft-versus-host disease (GvHD) and overall survival (OS).
• To evaluate the effectiveness of current management strategies in mitigating risks.

Main Methods:

• Review of existing literature on red cell-incompatible hematopoietic stem cell transplantation.
• Analysis of immunohematological complications and transplant outcomes.
• Consideration of mouse models and human studies on blood cell antigens as minor histocompatibility antigens.

Main Results:

• Risks of hemolytic reactions and aplasia can be reduced by graft processing and blood component support.
• Red blood cell antigens expressed on tissues may influence GvHD risk, though current regimens appear to mitigate this.
• No consistent deleterious effects on engraftment, GvHD, relapse, or OS have been demonstrated, but studies are often limited.

Conclusions:

• While red cell-incompatible transplantation presents risks, graft processing and supportive care ameliorate these complications.
• Current conditioning and immunosuppressive regimens seem to overcome potential negative impacts of blood cell antigen disparities.
• Further research with larger, standardized cohorts is needed to definitively assess the effects of ABO-incompatible transplantation on transplant outcomes.